Alembic Limited, the pharmaceutical major, announced its quarterly un-audited numbers for the 1 Quarter ended on 30th June, 2006.
The company´s total income up by 6% at Rs. 15122 Lacs, profit before tax higher by 14% at Rs.1417 Lakhs, profit after tax higher by 68% at Rs.1825 Lakhs.
The export formulation sales up 222% to Rs.1778 Lakhs and the company reported an EPS of Rs.6.59 compared to Rs.3.91 for the corresponding previous quarter.
Domestic formulation registered a slight decline due to spill over effect of VAT implementation issues in corresponding quarter of previous year. In normalized situation growth would have been 11-12%. Sales to regulated market for the quarter amounts to Rs. 1889 lacs as compared to Rs. 410 Lacs for corresponding quarter in previous year.
The Board of Directors has approved to split the face value of the equity shares of the Company from Rs. 10/- per share to Rs. 2/- per share subject to the approval of shareholders of the Company at the Annual General Meeting of the Company to be held on 30 August 2006.